administrative expenses to revenues stood at 16.2%. Finance Cost Finance Cost for the year of 2018 was 133.6 million, decrease from 2017 56.7 million Baht or 73.8% increase. Major of the Company’s liabilities in
from the end of the previous year. It was a result of a decrease in the temporary investment fund by Baht 4.91 million. The inventory increased by Baht 6.71 million. The advance payment of share and
Performance (Income Statement) Q3.2018 Q3.2018 Increase/(decrease) % Income Income from Sale of Goods 140,004 151,554 (11,550) (7.62) Income from Sevice 81,443 - 81,443 100.00 Cost of Sale of Goods (108,549
tax assets 0.42 0.20 0.22 106.14 Total non-current assets 358.23 375.01 (16.78) (4.48) Details 31 Dec 2017 31 Dec 2016 Increase (Decrease) Percentage Total assets 729.13 561.39 167.74 29.88 Current
. Revenue from sale of industrial equipment dropped by 20.40% due to decrease in demand on products. Other revenues comprise of revenue from revenue from sale of scrap and zinc, machinery rental, together
from 77.3 percent to 87.3 percent and Ms. Kanjana Pongpatanadecha’s shareholding proportion shall decrease from 18.7 percent to 8.7 percent. The Company is therefore obligated to comply with the
Owners of the parent 27.96 8.19% 41.21 34.30% (13.25) (32.15%) Jan – Mar 63 Jan – Mar 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดั
revenue decreased by 9.32% year-on-year. Sales and service income decreased by 10.60%, with 5.93% increase in automotive parts businesses but 46.72% decrease in dealership businesses. The automotive part
2021 As at 31 December 2020 Increase/ (Decrease) % Increase/ (Decrease) Total assets 653.74 183.22 470.52 256.81% Total Liabilities 104.43 92.66 11.77 12.70% Total Equity 549.32 90.56 458.75 506.58